Follistatin-like protein-1 is a novel proinflammatory molecule.
about
DIP2A functions as a FSTL1 receptorDIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteinsFSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expressionFollistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cellsCardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overloadTherapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical modelsFollistatin-like 1 in vertebrate developmentFollistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-1β secretion from monocytes and macrophagesIdentification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/ConnemiR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.Activins and follistatins: Emerging roles in liver physiology and cancerFollistatin-like 1 regulates renal IL-1β expression in cisplatin nephrotoxicity.Vitamin D-responsive SGPP2 variants associated with lung cell expression and lung functionImpaired elastin deposition in Fstl1-/- lung allograft under the renal capsule.Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma.Akt fine-tunes NF-κB-dependent gene expression during T cell activationFollistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis.Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis.Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formationAssociation of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy MenLectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant stateGene expression profiling in dermatitis herpetiformis skin lesions.The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M.Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection FractionMitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cellsFollistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.Follistatin-like 1: a potential mediator of inflammation in obesity.Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.Follistatin-like protein 1 contributes to dendritic cell and T-lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N-terminal kinase expression.Diverse biological functions of the SPARC family of proteins.New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.
P2860
Q24294331-B9869159-2F67-49FC-8BD7-E8D2C272E82EQ24300552-F8AB9AAF-3A70-467F-AF80-0F4E95CFEF33Q24633625-DB9D2488-42CF-408A-B62F-761711A527AEQ28236139-C80DDF30-3E61-49C0-BE0D-1D17F79B5B53Q28250153-08975FE6-558B-43CF-A73F-457C4AC10F86Q28273799-4A2D6A11-429F-4536-AE70-767E2FCC69F6Q28291738-DF133DC4-17E2-422A-A203-A42AF2E93E19Q28306794-7FF4ABBC-7B29-4F5B-B0CD-392AB656DDA2Q33301092-73D82C24-3179-4FB6-BBD9-508EFD6E2332Q33400321-AE1D7DFB-D0E5-4844-AD3F-60979FA92445Q33882469-1B76B0B7-387E-481F-A46F-8F2271B48256Q34063418-B7315007-B017-4596-9813-86FF8241EDF7Q34391497-20599EF4-1147-4A7F-9BD1-0E9013A2A963Q34426354-00F7053D-4584-4522-9B8F-BA0E690065CDQ35052582-4B476B50-6985-48C3-97B2-9982693A7502Q35055283-574BBEFE-4617-4A31-8D0B-1639DE7A2977Q35064880-F456C69B-7926-4BE9-8BFF-333F3E0CCEB9Q35148052-953C60CB-D963-4EFB-B142-6288E45D5DF4Q35371427-CD781AB6-0CD9-45D6-B72B-C035FCBAAE6FQ35620310-199354EB-04AA-48C3-B26F-B1113F2218F1Q35907752-43A05ED9-DF6A-49AA-8C95-18A99FB7EE99Q35951695-A33F9D6F-0D0B-421D-AA2D-BDBD3C55DF24Q36008387-E4F94969-3688-48AF-9C4C-2AC2A42880F2Q36058024-4CA7CA8B-895F-49C1-9786-04132859B044Q36174961-933FAAC4-15AB-4267-B8F6-5C3D473A5AF8Q36237602-831B021E-9DCA-4923-A92C-6C02550E5D1DQ36278850-58766AC2-554C-4F2B-A59A-92F5BB365D96Q36346681-2CBF76A3-EB72-4FFE-9F1D-C851B5D2D049Q36738068-418306A2-8AE8-499A-ABAF-E8D9C2C1158DQ36986322-7F046766-3BF7-4F36-BF71-2A43FDD7EA2EQ37086051-8A28F175-D07B-4F33-B8E0-43C000312287Q37094365-F6B22ED3-3D4F-4BB1-AD40-5D9B532E2B3EQ37109684-D8BF3D28-FF23-45F7-81B4-D5EE2F646E55Q37141388-58644CA3-30DF-4295-BDC8-1CDF66F0A384Q37380043-FA36C50E-F6CC-48A0-8504-7F1E2623FA14Q37451624-0646994F-6A28-45A5-B889-C2C3A86B8B18Q37560999-CAA2C83E-3865-4A68-A64E-ECA8925EFF01Q37976223-05DFEAAF-4328-4B75-A890-F8BD382BE95AQ38100987-2C7C3A5C-DF26-46A8-B910-672A9094AC8DQ38212545-0F6E44E7-5E51-47B6-A66E-B169DE9F9929
P2860
Follistatin-like protein-1 is a novel proinflammatory molecule.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Follistatin-like protein-1 is a novel proinflammatory molecule.
@en
Follistatin-like protein-1 is a novel proinflammatory molecule.
@nl
type
label
Follistatin-like protein-1 is a novel proinflammatory molecule.
@en
Follistatin-like protein-1 is a novel proinflammatory molecule.
@nl
prefLabel
Follistatin-like protein-1 is a novel proinflammatory molecule.
@en
Follistatin-like protein-1 is a novel proinflammatory molecule.
@nl
P2093
P1476
Follistatin-like protein-1 is a novel proinflammatory molecule
@en
P2093
Anthony D Marinov
David C Wilson
Dawn Sowders
Jason Devlin
Paul Robbins
Robert Boudreau
Takako Miyamae
P304
P356
10.4049/JIMMUNOL.177.7.4758
P407
P577
2006-10-01T00:00:00Z